Inactive Instrument
Ceapro Inc. Stock
Stocks
CZO
CA1499071076
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -11.76% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 72 | 21/06/2012 |
| Director of Finance/CFO | - | - | |
Michael Teifel
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Gagnon
BRD | Director/Board Member | 72 | 01/01/2007 |
William Li
BRD | Director/Board Member | 63 | 20/11/2014 |
Ulrich Kosciessa
BRD | Director/Board Member | - | 28/04/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/6/24 | Marche | Director | 210,000 | 0.2682% | ||
| 7/6/24 | Marche | Director | 230,000 | 0.2938% | ||
| 7/6/24 | Marche | Chief Executive Officer | 700,000 | 0.8941% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -11.76% | -16.67% | - | - | 12.8M | ||
| +1.09% | +5.26% | +4.44% | +26.03% | 51.22B | ||
| -1.38% | +2.74% | +473.74% | +600.70% | 45.38B | ||
| +2.23% | +8.58% | +20.16% | +92.37% | 41.97B | ||
| +0.98% | +9.22% | +39.42% | +20.58% | 42.15B | ||
| -0.93% | -4.80% | +17.39% | +46.60% | 31.95B | ||
| +0.29% | +3.17% | - | - | 16.73B | ||
| +2.05% | +7.69% | +37.42% | +153.26% | 17.1B | ||
| +0.03% | +3.41% | +7.12% | +35.49% | 14.76B | ||
| +1.84% | +6.03% | +92.15% | +47.80% | 13.91B | ||
| Average | -0.57% | +3.19% | +86.48% | +127.85% | 30.58B | |
| Weighted average by Cap. | +0.57% | +3.13% | +103.76% | +149.50% |
Employees
-
















